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Abstract
Neospora caninum is recognised worldwide as a major cause of bovine infectious abortion. There is a real need to
develop effective strategies to control infection during pregnancy which may lead to either abortion or congenital
transmission. Due to the intracellular nature of the parasite, cell-mediated immune (CMI) responses involving CD4
+ve,
CD8
+ve, g/δ TCR
+ve T cells and NK cells, as well as production of IFN-g, are thought to be important for protective
immunity. In this study we applied a combination of proteomic and immunological approaches to identify antigens
of N. caninum that are recognized by CD4
+ve T cell lines derived from infected cattle. Initially, N. caninum tachyzoite
Water Soluble Antigens (NcWSA) were fractionated by size-exclusion HPLC and then screened for immune-potency
using CD4
+ve T cell lines. LC-ESI-MS/MS (liquid chromatography electrospray ionisation tandem mass spectrometry)
was employed to catalogue and identify the proteins comprising three immunologically selected fractions and led to
the identification of six N. caninum target proteins as well as sixteen functional orthologues of Toxoplasma gondii.
This approach allows the screening of biologically reactive antigenic fractions by the immune cells responsible for
protection (such as bovine CD4
+ve cells) and the subsequent identification of the stimulating components using
tandem mass spectrometry.
Introduction
Neospora caninum is a protozoan parasite, closely related
to Toxoplasma gondii, which has emerged as a major
cause of reproductive failure in cattle worldwide [1,2].
The parasite is now recognised as the most commonly
diagnosed cause of abortion in areas with an intensive
dairy industry [3]. Infection during pregnancy may result
in abortion, depending on the stage of gestation when
parasitaemia occurs, or may lead to the birth of a conge-
nitally infected calf [4]. Treatment options are limited,
with few chemotherapeutics available which may be pro-
blematic to use in meat or milk-producing livestock.
Applying management and biosecurity measures such as
those detailed in a management scheme recently
launched by Defra in the UK (Herdsure) [5], may help to
reduce infection levels in the herd; culling of seropositive
animals has also been suggested as a method of control
[6]. All these approaches can constitute a substantial cost
for the farming industry.
T h e r ei sa c c u m u l a t i n ge v i d e n c et h a tc a t t l ep r e v i o u s l y
exposed to the parasite are less likely to abort than those
undergoing a primary infection [7] suggesting the devel-
opment of some form of protective immunity and the
feasibility of a vaccination approach. To date only one
commercial vaccine [8], based on an inactivated tachy-
zoite preparation adjuvated with Havlogen [9], has been
registered in some countries. This vaccine demonstrated
variable reduction in the number of abortions under field
challenge condition in Costa Rica [10] and New Zealand
[11]. However, it did not prevent foetal infection [12] and
did not allow discrimination between vaccinated and
naturally infected animals. Studies that have focussed on
the evaluation of N. caninum tachyzoite proteins as vac-
cine candidates in mouse models have given ambiguous
results, ranging from 70-90% protection using live atte-
nuated tachyzoites [13] to very little or no protection
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immunisation with live attenuated organisms is more
effective than killed organisms, presumably as a reflection
of more efficient antigen processing and presentation to
T cells.
Immunological screening requires knowledge of the
immune mechanisms responsible for protection, the so-
called correlates of protection [15]. Cattle infected with N.
caninum produce parasite-specific antibodies although
their contribution to protective immunity is not clear
[7,16]. There is mounting evidence that, as for other intra-
cellular protozoan parasites, the most important correlate
of protection for N. caninum is the establishment of a cell
mediated immune response [7,17]. In vitro studies have
shown that treatment of cultured cells with recombinant
interferon gamma (IFN-g) ,ac y t o k i n ep r o d u c e db ya c t i -
vated T-lymphocytes, significantly inhibits the intracellular
multiplication of N. caninum [18]. A number of studies
have also demonstrated that activated T-lymphocytes can
recognise and respond to parasite-infected cells by produ-
cing inhibitory cytokines [19,20]. Staska et al. have shown
a T-helper type 1 response in infected cattle involving
CD4
+ve cytotoxic T cells and IFN-g production [21],
whereas Boysen et al. showed that cytotoxic NK cells also
play a role in the control of the disease through both cyto-
toxic and an IFN-g mediated mechanisms [22]. Therefore,
the development of vaccines directed against N. caninum
should focus on selecting antigens that are capable of eli-
citing mainly a cell mediated immune response involving
CD4
+ve T cells and IFN-g, in addition to a serological
response.
The aim of this work was to identify N. caninum tachy-
zoite antigens that are recognised by the cell-mediated
immune (CMI) response of experimentally infected ani-
mals. Neospora caninum water soluble antigens were initi-
ally separated by size exclusion HPLC and tested for their
ability to induce proliferative responses in a NcWSA-spe-
c i f i cb o v i n eC D 4
+ve test system. A number of fractions
which consistently induced significant proliferative
responses were further investigated by tandem mass spec-
trometry allowing the identification of the proteins pre-
sent. This type of approach demonstrated that is possible
to use biologically relevant screening tools to select T-cell
reactive fractions, thus facilitating the downstream analysis
of relevant candidate vaccine antigens for Neospora
caninum.
Materials and methods
Experimental design
Neospora caninum water-soluble antigen (NcWSA) was
subdivided into smaller, less complex protein pools by
size exclusion HPLC. Three identical aliquots of the
same preparation of NcWSA were run in three consecu-
tive size exclusion separations and tested in vitro for
immune recognition by short-term NcWSA specific
CD4
+ve cell lines derived from cattle experimentally
infected with N. caninum. Immuno-reactive fractions
were subjected to SDS-PAGE and LC-ESI-MS/MS prior
to downstream database mining and bioinformatic analy-
sis to identify their respective protein compositions.
Parasites, inocula and immunisation schedules
Neospora caninum tachyzoites (NC1 isolate) [23] were
maintained in Vero cells as previously described [18] and
used to prepare infectious inocula as detailed below.
Experimental live tachyzoite challenge confers protection
against abortion [24] and has been employed in the past
by us and other groups to characterise protective immune
responses [25,26]. Calves (see below) were infected subcu-
taneously over the left pre-femoral lymph node with the
live inoculum containing 1 × 10
8 tachyzoites per calf.
A control inoculum containing an equivalent number of
Vero cells as present in the parasite inocula was adminis-
tered to control calves. All experimental animals employed
in this study were reared, housed and handled in accor-
dance to the UK Animals (Scientific Procedures) Act
1986; the experimental design was approved by the
Moredun Ethical Review Committee. Five male calves,
dehorned and castrated, aged two months and serologi-
cally negative for N. caninum antibodies by IFAT [27] and
a commercial ELISA (NC Herdcheck, IDEXX Labora-
tories, Chalfont St Peter, UK) were randomly assigned to
two groups. Three animals received the infectious inocu-
lum whereas the two remaining animals received the con-
trol. Rectal temperatures were monitored from day 2
to day 14 post-infection (pi) and blood samples were
collected up to one month post-infection for serological
analysis. Seroconversion was confirmed by ELISA. Twelve
months after the first inoculation the animals were
boosted with a further similar dose of either live
N. caninum tachyzoites or control Vero cell inoculum.
Lymphocyte Transformation Tests (LTT)
Initiation of a CMI response was confirmed by LTT (Lym-
phocyte Transformation Test) on Peripheral Blood Mono-
nuclear Cells (PBMCs) isolated according to previously
published protocols [28]. Briefly, PBMCs were resuspended
in cell culture medium (CCM) (comprising IMDM [Gibco,
Invitrogen, Paisley, UK], 10% heat inactivated foetal bovine
serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin,
100 μg/mL streptomycin and 5 μg/mL Amphotericin B [all
from Sigma, Gillingham, UK]). PBMCs were cultured in
96-well plates (Nunc, Roskilde, Denmark) at concentration
of 2 × 10
5/well and stimulated with 200 ng/well of antigen
(NcWSA-see below) for 5 days in a humidified 5% CO2
atmosphere at 37°C. Controls included cell culture media,
Concanavalin A (ConA) (1 μg/well, Sigma, UK) and Vero
cell lysate (200 ng/well). Cultures were pulsed with 1 μCi
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3H]-thymidine (GE HealthCare, Bucks, UK) for the final
18 h of incubation. Cells were harvested onto glass fibre fil-
ters (Wallac, Turku, Finland) and [
3H]-thymidine incor-
poration quantified using an automated scintillation
counter (Perkin Elmer, Cambridge, UK) and expressed as
counts per minute (CPM), with each test performed in
quadruplicate. Stimulation indices (SI) were calculated by
dividing the median value of the test by the median value
of the media control.
Preparation of N. caninum Water-Soluble Antigen (NcWSA)
NcWSA was produced as follow: 1-2 × 10
9 tachyzoites,
prepared accordingly to previously published methods
[29] were washed three times in PBS (650 × g for 5 min)
then stored at -20°C prior to antigen preparation. After
thawing, tachyzoites were suspended in distilled water
and disrupted by three cycles of freezing and thawing in
liquid nitrogen followed by homogenisation using a Pre-
cellys tissue homogenizer (Precellys, Bertin Technologies,
Tarnos, France). The homogenised suspension was cen-
trifuged at 10 000 × g for 30 min at +4°C to recover the
supernatant containing the N. caninum WSA. Protein
concentration was assessed using the BCA reagent
(Pierce Chemicals, Rockford IL, USA). NcWSA was then
aliquotted and stored at +4°C prior to chromatographic
fractionation, which was performed within 24 h of anti-
gen preparation.
Size exclusion HPLC of NcWSA
Size exclusion chromatography was performed using a
Beckman System Gold HPLC apparatus (Beckman Coulter,
High Wycombe, UK) in combination with a Superose 12
gel filtration column (GE Healthcare) pre-equilibrated with
PBS pH 6.8. Individual 200 mL injections of 0.45 mm-
filtered NcWSA (935 mg total protein) were applied to the
column and the proteins resolved isocratically in PBS pH
6.8 at a flow rate of 0.5 mL/min over a period of 60 min.
Proteins eluting from the column were monitored by UV
(280 nm) and chromatographic data was recorded and
analysed using 32 Karat Gold ™ chromatograpy analysis
software (Beckman Coulter). Fractions of 1.0 mL were col-
lected and stored at +4°C in sealed low-protein-binding
tubes (Eppendorf, Cambridge, UK) until required. Repro-
ducibility of the fractionation was confirmed by overlaying
the chromatograms of three consecutive separations as
s h o w ni nr e s u l t s .
Protein quantification of individual antigen fractions
was performed using the NanoOrange
® protein quantifi-
cation kit (Molecular Probes, Invitrogen, Paisley, UK) in
accordance with the manufacturer’s instruction and an
automated fluorescence reader (CytoFluor, PerSeptive
Biosystems, Framingham, MA, USA). Protein concentra-
tions were then adjusted between fractions to ensure
equal concentration of each fraction used in the T-cell
lines proliferation assays, and fractions were stored at
-20°C until required for the T cell assay.
Generation and characterization of bovine CD4
+ve T cell
lines and antigen screening assay
Short-term antigen specific T cell lines were prepared
from the infected animals as follows: for the first round of
stimulation each well of a 96-well round bottom tissue
culture plate (Nunc, Denmark) was seeded with 2 × 10
5
freshly isolated PBMCs resuspended in CCM and stimu-
lated with 200 ng NcWSA. Cells were cultured at 37°C in
a humidified 5% CO2 atmosphere for seven days then har-
vested, washed (300 × g for 10 min), resuspended in CCM
supplemented with 10 U/mL of recombinant human IL-2
(rhu IL-2, Proleukin, Novartis, East Hanover NJ, USA) and
seeded into fresh 96-well round bottom plates. Six days
later an aliquot of cells was removed for phenotypical ana-
l y s i sa n dt h er e m a i n i n gc e l l sw e r ec u l t u r e df o raf u r t h e r
24 h prior to use in the antigen screening assay. The phe-
notypic composition of the short-term T cell lines was
analysed using a panel of monoclonal antibodies (MoAbs)
recognizing specific bovine leukocyte populations accord-
ing to previously published methods [30]. Antibody bind-
ing was revealed with Alexa 488-conjugated anti-mouse
IgG (Invitrogen, UK) (0.5 μg/mL final) and data acquired
using a CyAn flow cytometer (CyAn, Dako-BeckmanCoul-
t e r ,U S A )e q u i p p e dw i t ha4 8 8n ma r g o n - i o nl a s e ra n d
analyzed using Summit software (Dako, Fort Collins, CO,
USA). A minimum of 10 000 cells were acquired for each
sample.
These short term lines prepared from the three infected
animals were used to test each fraction generated from
the three different HPLC runs (n = 9). Test wells for the
T cell lines screening assays were set up in triplicate in
96 well round bottom tissue culture plates. Each well
contained 5 × 10
4 T cells, 5 × 10
5 autologous antigen
presenting cells (APC) (3000 rad g-irradiated PBMCs; at
a 1:10 ratio) and the different HPLC-separated fractions
(1-25) at a final concentration of 10 ng/well. Negative
controls comprised T cells or APCs with medium only as
well as APCs plus T cells with only CCM or with Vero
lysate. Positive controls included T cells, APCs or APCs
plus T cells cultured with 500 ng/well ConA or unfractio-
nated NcWSA with a final concentration comprised
between 200 and of 10 ng/well. Cells were cultured at
37°C in a humidified 5% CO2 atmosphere and prolifera-
tion was quantified by
3H-thymidine incorporation as
described previously for the proliferation assay.
Shotgun proteomic analysis of selected reactive fractions
All protemics-based analysis were performed by the
Moredun Proteomic Facility, (Moredun Research Insti-
tute, Penicuik, UK). A pool of each homologous fraction
selected on the basis of the CD4
+ve Tc e l lr e a c t i v i t yw a s
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brane cut-off 3 kDa), snap-frozen in liquid nitrogen
then freeze-dried. Each pellet was resuspended in 25 μL
of reducing SDS-PAGE sample buffer, heated at 95°C
for 5 min, separated using a SDS-PAGE gel (4-12%
Tris-glycine gradient, NuPage, Invitrogen, UK) and
finally stained with Simply Blue Safe Stain ™ (Invitro-
gen, UK). The gel lanes were excised in their entirety
then divided equally into slices of 2.5 mm deep to yield
25 gel slices. Each slice was then de-stained before pro-
cessing using standard in-gel reduction, alkylation and
trypsinolysis procedures [31]. The resulting peptides
were analysed by Liquid Chromatography Electrospray
Ionisation Tandem Mass Spetrometry (LC-ES-MS/MS)
using a U3000 nano-flow UHPLC apparatus (Dionex,
Camberley, UK) and amaZon high capacity ion trap
mass spectrometer (Bruker, Coventry, UK). Parameters
for tandem MS analysis were set as previously described
[32]. Processed MS/MS data, in mascot generic format
(mgf), was mined against a) the NCBInr database [33]
using alveolata as taxonomical search and b) a cognate
Neospora caninum genomic database (N.c. Liverpool
strain) [34]. The presentation and interpretation of MS/
MS data was performed in accordance with published
guidelines [35]. A more detailed description of the Tan-
dem Mass Spectrometry procedure can be found in the
additional file 1.
Results
Clinical and immunological reactivity after challenge
Between 72 and 96 h after the initial N. caninum chal-
lenge, the infected animals showed pyrexia and swelling of
the ipsilateral draining lymph nodes, whereas the negative
control animals remained normal. In the infected animals
seroconversion was demonstrated 14 days post infection
(dpi) by ELISA (data not shown) and antigen specific CMI
responses were detected one month after infection by
LTT (SI values between 14 and 135). Control animals
showed no seroconversion or antigen-specific responses
(SI values between 2 and 3; data not shown). Twelve
months after the initial challenge the infected animals
were inoculated with a second live immunisation, using a
similar dose and route as described in material and meth-
ods. Following the second immunisation, LTT reactivity
was evident and serological reactivity was demonstrated
using Western blot analysis (an example of Western blot
reactivity is shown in an additional figure - additional file
2). The animals were employed to prepare CD4
+ve Tc e l l
lines starting from three weeks after the second challenge.
HPLC fractionation of N. caninum water-soluble antigen
Corresponding fractions (1-25) from each of three identi-
cal size exclusion separations of NcWSA were combined
to yield 25 pooled fractions. Chromatograms of each
separation were superimposed to demonstrate consis-
tency over the three replicate runs (Figure 1A). In addi-
tion, similarity between homologous fractions obtained
from the three consecutive runs was confirmed by SDS-
PAGE analysis on three representative fractions (Figure
1B). An example of SDS-PAGE analysis of the HPLC-
separated fractions is shown in an additional figure (see
additional file 3). These results demonstrate the robust-
ness of the HPLC fractionation and show that this is
independent from the size of the separated proteins.
Antigen fraction screening using CD4+ve T cell lines
Short term stimulation of immune PBMCs with NcWSA
and IL-2 produced 2-week old cell lines that consistently
comprised a majority of CD3
+ve and CD4
+ve T cells
(CD3
+ve: average 97%, min 94.3% and max 98.5%; CD4
+ve
average 87%, min 77.2% and max 93.2%) with very low
CD8
+ve and g/δ TCR
+ve T cells contamination (on average
less than 5% for CD8 and 8% for g/δ TCR
+ve). These cells
were employed in the T cells assays for the antigen frac-
tion screening test where we identified three fractions
(fractions 3, 4 and 5) which consistently induced a cellular
reactivity above all the other fractions tested (Figure 2).
This reactivity corresponded, on the HPLC trace, to pro-
teins collected between 14 and 20 min. from the start of
the chromatographic separation. Fraction 3 showed the
highest reactivity, closely followed by fraction 4, whereas
fraction 5 was higher than all the remaining fractions but
to a large extent lower than 3 and 4. Despite the presence
of higher concentration of proteinaceous (as visualised by
SDS-PAGE, additional file 3) and non-proteinaceus mate-
rial (as deduced from the peaks in the HPLC trace) in
other fractions, the remaining fractions were only margin-
ally stimulatory to the T cell lines. In addition, fractions 17
to 25 consistently failed to induce reactivity above back-
ground level. On this basis, fractions 3, 4 and 5 were
selected for further analysis.
Proteomic analysis of selective reactive fractions
Proteins contained within fractions 3, 4 and 5, identified as
consistently reactive with the CD4
+ve T cell lines, were
separated by SDS-PAGE and catalogued by shotgun pro-
teomic analysis using LC-ESI-MS/MS. For each individual
fraction sample, a non-redundant list of identified proteins
was prepared, and a master list was generated, which
was termed as N. caninum reactive protein list (NCRP)
which comprises a total of six unique N. caninum proteins
(Table 1) as well as sixteen T. gondii homologues (Tables 2
and 3). Surface antigens, proteasome subunits, microneme
and dense granule proteins as well as some putative
uncharacterised proteins were identified. Three of the
N. caninum proteins were present both in fractions 3 and 4
(SAG1, SRS2 and GRA2), two were found exclusively in
fraction 3 (microneme protein Nc-MIC3 and GRA7) and
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Figure 1 Size exclusion fractionation of N. caninum Water Soluble Antigen. (A). Three identical aliquots of NcWSA were divided into
fractions comprising molecules of progressively lower mass by size exclusion HPLC. The superimposed absorbance profiles of the fractions
generated in three successive runs are shown. Horizontal axis: time, vertical axis: 280 nm absorbance. Fraction collection started 10 min into the
run, flow rate was 0.5 mL/min and a new fraction was collected every 2 min. The horizontal dotted lines indicate which portion of the NcWSA
antigen corresponded to each collected fraction; bold numbers above the dotted lines represent the fraction number, vertical numbers
represent retention time in minutes. (B): Silver stained SDS PAGE gel (4-12% Bis-Tris gradient) of three representative fractions (3, 7 and 11)
obtained in three separate runs (.1, .2 and .3) of size-exclusion chromatography. MW: molecular weight markers; 3.1: fraction 3 run 1; 3.2: fraction
3 run 2; 3.3: fraction 3 run 3; the numeration is equivalent for the further two fractions.
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neme protein NcMIC11). Homologues of T. gondii proteins
identified comprised surface, ribosomal, proteasome, his-
tone and rhoptry proteins, seven of which were identified
in fraction 3, nine in fraction 4 and three in fraction 5. In
some cases the same protein was indentified in contiguous
fractions (Table 2) however, the majority of T. gondii
homologues were present exclusively in a single fraction
(Table 3).
Discussion
The primary objective of this work was to identify
immunologically (cell mediated) relevant antigens of
N. caninum, using a combination of proteomics-based
and immunological approaches. As CD4
+ve T cells are
important in disease protection [17] we expanded
immune precursors from this population to screen
tachyzoite antigens generated through size exclusion
fractionation. Selected fractions were then analysed by
LC-ESI-MS/MS to catalogue their respective protein
profiles. This initial immuno-potency screening of the
soluble fractionated antigens was deemed necessary
because, whilst proteomic characterisation of an organ-
ism provides information on its composition and com-
plexity, it does not always reflect the relative
immunological importance of the molecules identified.
We initially demonstrate that size-exclusion fractiona-
tion using an aqueous mobile phase is highly reproducible
and generates material that is free of detergents and salt
concentrations that are incompatible with the in vitro
CD4
+ve test, and for the same reason we opted to use a
soluble preparation of the parasite as starting material.
A selection based on Western blot reactivity (see addi-
tional file 2) would have suggested deeper interrogation of
fractions 2 to 7, which correspond to the majority of the
proteins present in the original water soluble antigen.
However, a comparison of the serological reactivity pro-
files with the cellular reactivity suggested that only frac-
tions 3, 4 and 5 would benefit from a further analysis.
Shotgun proteomics analysis of the selected fractions led
to the identification of six N. caninum reactive proteins as
well as sixteen functional orthologues of T. gondii
proteins.
Among the six proteins identified from mining the N.
caninum database and common to both fractions three
and four were the surface antigens SAG1 and SRS2 and
the dense granule protein GRA2. SAG1 is a tachyzoite gly-
cosylphosphatidylinositol (GPI)-anchored surface molecule
[36] thought to be implicated in host cell attachment and
invasion [37] and is serologically immunodominant [38].
Recombinant SAG1 immunisation has been attempted
with inconsistent results in rodents using a vaccinia virus
delivery vector [39], a cDNA prime-protein boost regime
c
.
p
.
m
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Figure 2 Proliferation of CD4
+ve T cell lines in response to the
fractionated N. caninum water-soluble antigen. Average
proliferative response of 9 different cell lines (three each from three
animals) to the first 16 HPLC fractionated antigen preparations.
Results are expressed as count per minute (cpm-vertical axis). F1-F16
represents the fraction number. Each box plot spans the interquartile
range of cpm values, with the inside line indicating the median
value. Whiskers extend as far as the minimum and maximum values.
The fractions selected for further proteomic analysis are shadowed.
Fractions 17 to 25 were not recognised or recognised at background
level by the cell lines and are not represented in the figure.
Table 1 NCRP list of N. caninum proteins identified in reactive fractions
Fraction
(s)
Accession Gene
name
Description MOWSE Peptides
Matched
Example Peptides
3, 4 AAD25091 SAG1 Surface antigen SAG1* 1048 9 K.EIPLESLLPGANDSWWSGVDIK.T; K.SVSSPEVYCTVQVEAER.
A
3, 4 AAX38598 SRS2 Surface protein SRS2** 760 9 K.LLSEDDGLIVCNESDGEDECEK.N; R.
LRPITVNPENNGVTLICGPDGK.A
3, 4 AAG28489 GRA2 GRA2 protein 287 4 R.GTVNGQPVGSGYSGYPR.G; R.ESMAAPEDLPGER.Q
3 AAF19184 MIC3 Microneme protein Nc-
MIC3
219 5 K.NPMCYPTCEEMGGK.D; K.DAECVEDLNAGGSVR.C
3 P90661 DG1 GRA7*** 116 2 K.LAVPVVGALTSYLVADR.V; R.VLPELTSAEEEGTESIPGK.K
4 AAN16380 NcMic11 Microneme protein
NcMIC11
137 2 K.STAVEIFK.Q;
K.AAIVEGVKPMLPK.L
* also known as Nc-p29 or Nc-p36; ** also known as Nc-p35 or Nc-p43; *** also known as NCDG1 [39].
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localised on the surface of N. caninum of both bradyzoites
and tachyzoites [43], is involved in the host cell invasion
process [44] and its neutralisation inhibits parasite attach-
ment and in vitro invasion of placental trophoblasts [45].
By homology with T. gondii we also identified a second
SRS domain-containing protein in fractions 3 and 4, in
addition to the N. caninum SRS2 protein. SRS-domain
containing proteins are considered extremely immuno-
genic in Toxoplasma [46] as well as being present in a
large number on the parasite surface, and are thought to
facilitate the invasion of multiple host and cell types [47].
Therefore the identification of more than one of these
proteins in our N. caninum reactive fractions is perhaps
not surprising. NcSRS2 has been selected as candidate
antigen for vaccination by a number of groups. Rodent
challenge with N. caninum following vaccination with
NcSRS2 demonstrated improved survival [41] reduced
transplacental transmission [48] and the development of
humoral and cellular immune responses to N. caninum
tachyzoites [49]. In cattle, NcSRS2 peptide-specific T lym-
phocytes have been detected ex vivo in peripheral blood of
infected animals [21]. Baszler et al. [50] also demonstrated
the induction of a cell-mediated immune response similar
to that induced by the live parasite in animals vaccinated
with NcSRS2 in combination with Freund’sa d j u v a n t .
Table 2 Homologues of T. gondii proteins identified in more than one fraction
Fraction Accession Gene
name
Description MOWSE Peptides
Matched
Example Peptides
3, 4 XP_002369822 SRS domain containing
proteins
821 16 K.IDLDPEDLHGHVYLPLVEQVDPMR.L; K.
DLGQFGYVPPGDGRDPAGDEVQECK.Y
4, 5 XP_002365950 Glutamine synthetase,
putative
168 4 K.IDPPPPADCDAAEVDSPLVR.S; R.TLVDAADLMMVYK.Y + 2
Oxidation (M)
4, 5 EEE20214 20S Proteasome subunit
alpha
194 4 K.VEVEVGLIGNDSCGVFK.M; R.IAAVTETIGIAVAGLAADGR.Q
Table 3 Homologues of T. gondii proteins identified in only one fraction
Fraction Accession Gene
name
Description MOWSE Peptides
Matched
Example Peptides
3 EEE22451 Putative uncharacterized
protein
837 7 K.LEVGETCTIEMLPQNSK.V; K.HKLEVGETCTIEMLPQNSK.V
3 EEE23072 Putative uncharacterized
protein
194 4 R.ATVHPGDTVTMQCPGAISSNPADVSK.Y; R.
LILDIEKSEEEVVR.T
3 EEE32684 Surface protein rhoptry
protein
135 2 K.SQANQGSPLPPPRPNLLR.R;
R.GLMSGVGWVK.R
3 EEE29336 Histone H4 110 2 R.ISGLIYEEIR.G;
R.DNIQGITKPAIR.R
3 XP_002370897 ROP 2 Rhoptery protein 2 91 3 R.DSGDVILEELFK.R;
K.GPSAIVFEATDR.E
3 EEE23774 Ribosomal protein S8 82 2 K.NSIVAIDATPFK.A;
K.LDPLLEEQFNTGR.L
4 AAD38419 HSP 60 283 4 K.QVASTTNDIAGDGTTTATLLAR.A; K.TLTHELELVEGLK.F
4 XP_002369317 Proteasome subunit alpha
(Type 2)
215 7 R.YNPDIELEDAIHTAILTLK.E; K.EGFEGAMNEHNIEIGVVGEDR.
K + Oxidation (M)
4 EEE23454 Proteasome subunit alpha
(Type 1)
182 3 K.ELSLDEIQALLDK.M; R.NFESFPGLSPEELELHAMK.A
4 XP_002366589 Proteasome subunit alpha
(Type 4)
162 4 K.EDLDVDAALLLAAK.V; K.QEWKEDLDVDAALLLAAK.V
4 EEE19215 Proteasome subunit Beta
[(Type 7)
100 2 K.GCAVVLGGVDFK.G;
R.VSMAVSVLSQELFK.Y
4 EEE25357 Proteasome subunit alpha
(Type 7)
129 2 K.DLVVLAVEK.K;
R.LNTATAPSVDYIAK.F
5 EEE30125 Cytosol aminopeptidase
putative
142 2 K.LTLFTDDVEAVNR.S
R.VVTSFLETLLVELQPDLR.F
Proteins were identified in each fraction by blasting the results of the peptide analysis versus the N. caninum and T. gondii genomic.
Proteins were identified in each fraction by blasting the results of the peptide analysis versus the N. caninum and T. gondii genomic databases. Table 1 lists
protein identified from the N. caninum database; Table 2 T. gondii homologues identified in more than one fraction and Table 3 T. gondii homologues present
only in one of the three fractions. MOWSE scores (for Molecular Weight Search) indicate the likelihood of having correctly identified a specific protein from the
molecular weight of the peptides created by its proteolytic digestion and measured with mass spectrometry. The dot (.) in the peptide sequence denotes trypsin
cleavage sites.
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Page 7 of 10In addition to surface expressed antigens, we also detected
dense granule antigens such as NcGRA2 (p29) and
NcGRA7. Neospora caninum GRA2 was originally identi-
fied by Ellis and collaborators [51] because of its signifi-
cant amino acid sequence homology (50%) with the GRA2
antigen of T. gondii; similarly NcGRA7 (or dense granule
protein 1) shows 42% identity with T. gondii GRA7 [42].
Dense granule antigens are specialised secretory organelles
belonging to the parasitophorous vacuole synthesized at
the time of infection and implicated in the cellular inva-
sion process [52] as well as in nutrient acquisition [53].
NcGRA2 is another immunodominant antigen and is
recognised by IgM from sera of N. caninum-infected cattle
[54]. E. coli expressed NcGRA2 demonstrated immuno-
genicity but only partial reduction in foetal infection and
pup mortality in a mouse model [55] and Ramamoorthy
reported that vaccination of mice with recombinant
NcGRA2 induced only partial protection against vertical
transmission [56]. Two microneme proteins (Nc-MIC3
and NcMIC11) were also identified in the reactive frac-
tions. Micronemes are secretory organelles which are
discharged by exocytosis during the attachment to the
host cell surface to facilitate cell invasion [57]. Despite
their low molecular weight, microneme proteins could
have been eluted in one of the early fractions as protein-
complexes, since most of them have putative adhesive
functions, are naturally secreted as multiprotein com-
plexes, and immunoprecipitation experiments in T. gondii
have confirmed that specific microneme proteins form a
stable complex within the microneme [58]. In analogy
with T. gondii, different microneme proteins such as
NcMIC11, an ortholog of TgMIC11 [59], NcMIC1 [58]
and NcMIC4 [60] have been identified in N. caninum but
so far only one, Nc-MIC3, has been associated with immu-
nological (serological) reactivity [36]. Use of microneme
proteins in vaccination and challenge studies has given
contradictory results in rodent models: vaccination with
NcMIC4 increased mortality following challenge [61]
whereas immunisation with NcMIC1 [62] or NcGRA7
[63] elicited only partial protection. Additional proteins
from cellular cytoplasm (rhoptries, ribosomes, HP60),
nucleus (hystones) as well as enzymes (proteasome com-
plex, glutamine synthetase, cytosol aminopeptidase) and
some additional molecules of unknown function were also
found in the reactive fractions by homology with T. gondii
proteome. The identification of TgROP2 homologue is
also promising since immunisation with recombinant
NcROP2 in a mouse model has been effective in reducing
mortality and cerebral infection [64], in addition to redu-
cing vertical transmission [65] when used in combination
with two microneme antigens (NcMIC1 and NcMIC3).
Involvement of proteasome genes in the generation of
a protective response to N. caninum in mice has been
recently suggested by Ellis [66] and HSP60 has been
identified as a serologically immunodominant protein
[54]. Neospora caninum rhoptry antigens have also been
identified as serologically immunodominant [67] while
in T. gondii, some of the rhoptries proteins have been
linked to increased virulence [68].
Cell-mediated antigen screening has in the past lead to
the identification of parasite fractions capable of being
recognised by memory T cells [69,70]. However, because
the antigenic components of the parasite were not identi-
fied, these previous studies did not allow the selection of
specific candidate antigens. Our approach, which com-
bines cellular screening and proteomic characterisation,
refines these previous investigations and show that it is
possible to streamline the screening of biologically reactive
fractions, narrowing the number of molecules of potential
interest to a manageable size. Each identified protein can
now be investigated to further select those capable of gen-
erating the correct in vivo immunological response.
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